In our previous work, we showed that phosphorylated nuclear LSD1 (phosphorylated at serine 111; nLSD1p) is enriched in breast cancer cell lines, chemotherapy-resistant MDA-MB-231 cancer xenografts in vivo, and CTCs isolated from patients with stage IV metastatic breast cancer (21). Here, KDM1A is linked to breast carcinoma.